Evidence map›Paper›PMID 30762459›Full record

ArticleActa orthopaedica2019

High annual surgeon volume reduces the risk of adverse events following primary total hip arthroplasty: a registry-based study of 12,100 cases in Western Sweden.

Per Jolbäck, Ola Rolfson, Peter Cnudde, Daniel Odin, Henrik Malchau, Hans Lindahl, Maziar Mohaddes

Abstract read
In one paragraph

Article in Acta orthopaedica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Complications in Total Joint Arthroplasties.Journal of clinical medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Per Jolbäcka Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.
Ola Rolfsona Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.
Peter Cnuddea Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.
Daniel Odinc Swedish Hip Arthroplasty Register , Gothenburg , Sweden.
Henrik Malchaua Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.
Hans Lindahla Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.
Maziar Mohaddesa Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose - Most earlier publications investigating whether annual surgeon volume is associated with lower levels of adverse events (AE), reoperations, and mortality are based on patient cohorts from North America. There is also a lack of adjustment for important confounders in these studies. Therefore, we investigated whether higher annual surgeon volume is associated with a lower risk of adverse events and mortality within 90 days following primary total hip arthroplasty (THA). Patients and methods - We collected information on primary total hip arthroplasties (THA) performed between 2007 and 2016 from 10 hospitals in Western Sweden. These data were linked with the Swedish Hip Arthroplasty Register and a regional patient register. We used logistic regression (simple and multiple) adjusted for age, sex, comorbidities, BMI, fiation technique, diagnosis, surgical approach, time in practice as orthopedic specialist and annual volume. Annual surgeon volume was calculated as the number of primary THAs the operating surgeon had performed 365 days prior to the index THA. Results - 12,100 primary THAs, performed due to both primary and secondary osteoarthritis by 268 different surgeons, were identified. The median annual surgeon volume was 23 primary THAs (range 0-82) 365 days prior to the THA of interest and the mean risk of AE within 90 days was 7%. If the annual volume increased by 10 primary THAs in the simple logistic regression the risk of AE decreased by 10% and in the adjusted multiple regression the corresponding number was 8%. The mortality rate in the study was low (0.2%) and we could not find any association between 90-day mortality and annual surgeon volume. Interpretation - High annual surgical activity is associated with a reduced risk of adverse events within 90 days. Based on these findings healthcare providers should consider planning for increased surgeon volume.

Indexed as

Arthroplasty, Replacement, HipOrthopedicsSurgeonsClinical CompetenceFemaleHospitals, High-VolumeHumansMaleMiddle AgedNeeds AssessmentPostoperative ComplicationsRegistriesRisk FactorsSweden

Identifiers

PMID30762459
PMCPMC6461084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.